Jerry Stitzel
Concepts (379)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Receptors, Nicotinic | 66 | 2024 | 322 | 9.400 |
Why?
| Nicotine | 44 | 2024 | 303 | 7.430 |
Why?
| Tobacco Use Disorder | 18 | 2024 | 239 | 2.680 |
Why?
| Nicotinic Agonists | 16 | 2020 | 125 | 2.660 |
Why?
| Prenatal Exposure Delayed Effects | 5 | 2021 | 551 | 1.490 |
Why?
| Smoking | 15 | 2023 | 1463 | 1.270 |
Why?
| Polymorphism, Single Nucleotide | 22 | 2023 | 2065 | 1.260 |
Why?
| Neurodevelopmental Disorders | 2 | 2021 | 151 | 1.250 |
Why?
| Brain | 22 | 2020 | 2618 | 1.210 |
Why?
| alpha7 Nicotinic Acetylcholine Receptor | 12 | 2017 | 101 | 1.060 |
Why?
| Polymorphism, Genetic | 12 | 2014 | 639 | 1.050 |
Why?
| Epigenesis, Genetic | 2 | 2021 | 616 | 1.020 |
Why?
| Mice | 58 | 2024 | 16579 | 1.000 |
Why?
| Hippocampus | 10 | 2019 | 795 | 0.900 |
Why?
| Mice, Inbred C3H | 15 | 2015 | 274 | 0.900 |
Why?
| Bungarotoxins | 19 | 2014 | 45 | 0.870 |
Why?
| Melatonin | 2 | 2015 | 121 | 0.820 |
Why?
| Protein Subunits | 8 | 2017 | 231 | 0.820 |
Why?
| Animals | 64 | 2024 | 34501 | 0.780 |
Why?
| Nerve Tissue Proteins | 9 | 2018 | 567 | 0.720 |
Why?
| Neurons | 4 | 2018 | 1448 | 0.680 |
Why?
| Synaptosomes | 6 | 2014 | 27 | 0.670 |
Why?
| Mice, Inbred DBA | 17 | 2015 | 182 | 0.670 |
Why?
| Mice, Inbred C57BL | 20 | 2019 | 5257 | 0.660 |
Why?
| Frontal Lobe | 2 | 2019 | 151 | 0.640 |
Why?
| Genetic Variation | 9 | 2022 | 934 | 0.620 |
Why?
| Nicotinic Antagonists | 7 | 2017 | 32 | 0.620 |
Why?
| Protein Precursors | 1 | 2019 | 126 | 0.620 |
Why?
| Brain-Derived Neurotrophic Factor | 1 | 2019 | 111 | 0.610 |
Why?
| DNA Methylation | 2 | 2021 | 604 | 0.610 |
Why?
| Choice Behavior | 5 | 2015 | 164 | 0.600 |
Why?
| Serine | 1 | 2018 | 136 | 0.590 |
Why?
| Wakefulness | 1 | 2018 | 114 | 0.580 |
Why?
| Substance Withdrawal Syndrome | 3 | 2018 | 171 | 0.570 |
Why?
| Gene Expression Regulation | 7 | 2013 | 2506 | 0.570 |
Why?
| Protein Processing, Post-Translational | 1 | 2020 | 450 | 0.560 |
Why?
| Sleep | 4 | 2018 | 672 | 0.550 |
Why?
| Species Specificity | 14 | 2012 | 567 | 0.530 |
Why?
| Motor Activity | 12 | 2022 | 667 | 0.520 |
Why?
| Sleep Wake Disorders | 1 | 2018 | 249 | 0.490 |
Why?
| Ethanol | 6 | 2022 | 585 | 0.490 |
Why?
| Receptors, Melatonin | 1 | 2015 | 2 | 0.490 |
Why?
| Glucocorticoids | 1 | 2019 | 575 | 0.470 |
Why?
| Gene Expression | 7 | 2015 | 1462 | 0.460 |
Why?
| GABA-B Receptor Agonists | 1 | 2014 | 4 | 0.460 |
Why?
| Receptors, GABA-B | 1 | 2014 | 9 | 0.460 |
Why?
| Baclofen | 1 | 2014 | 12 | 0.460 |
Why?
| Sensory Gating | 1 | 2015 | 44 | 0.460 |
Why?
| Drinking | 3 | 2015 | 41 | 0.440 |
Why?
| Polymorphism, Restriction Fragment Length | 7 | 2007 | 69 | 0.430 |
Why?
| Alcohol Drinking | 5 | 2022 | 749 | 0.430 |
Why?
| Behavior, Animal | 7 | 2019 | 490 | 0.430 |
Why?
| Schizophrenia | 4 | 2017 | 429 | 0.410 |
Why?
| Acetylcholine | 7 | 2012 | 183 | 0.410 |
Why?
| Circadian Rhythm | 2 | 2015 | 405 | 0.400 |
Why?
| Male | 52 | 2022 | 62883 | 0.390 |
Why?
| Bridged Bicyclo Compounds, Heterocyclic | 5 | 2018 | 215 | 0.380 |
Why?
| Pregnancy | 7 | 2021 | 6297 | 0.380 |
Why?
| Gene Targeting | 2 | 2011 | 82 | 0.380 |
Why?
| Mice, Inbred Strains | 10 | 2005 | 402 | 0.370 |
Why?
| Calcium | 3 | 2015 | 1178 | 0.370 |
Why?
| Dose-Response Relationship, Drug | 12 | 2012 | 1943 | 0.360 |
Why?
| Female | 51 | 2022 | 68127 | 0.360 |
Why?
| Mice, Knockout | 10 | 2018 | 2752 | 0.350 |
Why?
| Drug Discovery | 1 | 2011 | 130 | 0.340 |
Why?
| Administration, Oral | 4 | 2018 | 757 | 0.340 |
Why?
| Pyridines | 5 | 2018 | 469 | 0.340 |
Why?
| Seizures | 4 | 2007 | 395 | 0.340 |
Why?
| Gene Knock-In Techniques | 1 | 2010 | 52 | 0.340 |
Why?
| Rubidium | 4 | 2002 | 12 | 0.320 |
Why?
| Disease Models, Animal | 10 | 2023 | 3943 | 0.320 |
Why?
| Phenotype | 12 | 2023 | 3050 | 0.320 |
Why?
| Oocytes | 1 | 2010 | 175 | 0.310 |
Why?
| Taste | 2 | 2015 | 208 | 0.310 |
Why?
| Genetic Predisposition to Disease | 8 | 2022 | 2266 | 0.300 |
Why?
| Chromosome Mapping | 2 | 2006 | 505 | 0.300 |
Why?
| Promoter Regions, Genetic | 4 | 2015 | 1199 | 0.300 |
Why?
| Signal Transduction | 3 | 2019 | 4829 | 0.300 |
Why?
| Brain Chemistry | 2 | 2007 | 116 | 0.290 |
Why?
| Chlorisondamine | 1 | 2007 | 3 | 0.290 |
Why?
| Aging | 2 | 2022 | 1770 | 0.290 |
Why?
| Central Nervous System Depressants | 3 | 2005 | 83 | 0.290 |
Why?
| Genes, fos | 1 | 2007 | 33 | 0.280 |
Why?
| Neural Inhibition | 4 | 2017 | 152 | 0.270 |
Why?
| Corticosterone | 2 | 2019 | 214 | 0.270 |
Why?
| Mice, Transgenic | 4 | 2018 | 2069 | 0.270 |
Why?
| Genotype | 14 | 2014 | 1831 | 0.260 |
Why?
| Quantitative Trait Loci | 2 | 2015 | 356 | 0.250 |
Why?
| Microsatellite Repeats | 1 | 2006 | 161 | 0.250 |
Why?
| Ganglionic Stimulants | 1 | 2005 | 12 | 0.240 |
Why?
| Anxiety | 1 | 2012 | 949 | 0.240 |
Why?
| Genome-Wide Association Study | 6 | 2023 | 1337 | 0.240 |
Why?
| Corpus Striatum | 5 | 2019 | 157 | 0.230 |
Why?
| Multifactorial Inheritance | 2 | 2023 | 149 | 0.230 |
Why?
| Up-Regulation | 2 | 2018 | 826 | 0.220 |
Why?
| DNA-Binding Proteins | 2 | 2022 | 1415 | 0.220 |
Why?
| Choline | 2 | 2015 | 117 | 0.210 |
Why?
| Maze Learning | 3 | 2012 | 93 | 0.210 |
Why?
| Epistasis, Genetic | 1 | 2023 | 71 | 0.210 |
Why?
| Chronobiology Disorders | 1 | 2022 | 13 | 0.200 |
Why?
| Tobacco Use | 1 | 2022 | 61 | 0.200 |
Why?
| Genetic Markers | 2 | 2020 | 339 | 0.200 |
Why?
| Internationality | 1 | 2022 | 148 | 0.190 |
Why?
| Quinolizines | 3 | 2010 | 8 | 0.190 |
Why?
| Azocines | 3 | 2010 | 8 | 0.190 |
Why?
| Maternal Inheritance | 1 | 2021 | 15 | 0.190 |
Why?
| Alkaloids | 3 | 2010 | 25 | 0.190 |
Why?
| gamma-Aminobutyric Acid | 3 | 2014 | 158 | 0.190 |
Why?
| Humans | 39 | 2024 | 128524 | 0.190 |
Why?
| Alternative Splicing | 1 | 2003 | 218 | 0.190 |
Why?
| Benzazepines | 2 | 2012 | 40 | 0.180 |
Why?
| Varenicline | 2 | 2012 | 26 | 0.180 |
Why?
| Alzheimer Disease | 2 | 2022 | 515 | 0.180 |
Why?
| Calcium-Binding Proteins | 1 | 2022 | 211 | 0.180 |
Why?
| Quinoxalines | 2 | 2012 | 65 | 0.180 |
Why?
| Muscle Proteins | 1 | 2022 | 228 | 0.170 |
Why?
| Radioligand Assay | 3 | 2012 | 46 | 0.170 |
Why?
| Histone Deacetylase 2 | 1 | 2020 | 10 | 0.170 |
Why?
| Transcriptome | 2 | 2023 | 881 | 0.170 |
Why?
| DNA (Cytosine-5-)-Methyltransferases | 1 | 2020 | 31 | 0.170 |
Why?
| Dopamine | 3 | 2019 | 285 | 0.170 |
Why?
| Methyl-CpG-Binding Protein 2 | 1 | 2020 | 18 | 0.170 |
Why?
| Dioxygenases | 1 | 2020 | 29 | 0.170 |
Why?
| Amino Acid Substitution | 3 | 2009 | 281 | 0.170 |
Why?
| Muscle, Skeletal | 1 | 2010 | 1639 | 0.170 |
Why?
| Cell Line | 6 | 2017 | 2731 | 0.170 |
Why?
| Behavior, Addictive | 1 | 2020 | 81 | 0.160 |
Why?
| Furin | 1 | 2019 | 13 | 0.160 |
Why?
| Tacrolimus Binding Proteins | 1 | 2019 | 25 | 0.160 |
Why?
| Aequorin | 2 | 2012 | 2 | 0.160 |
Why?
| Body Temperature | 8 | 2015 | 215 | 0.160 |
Why?
| Sexual Maturation | 1 | 2019 | 52 | 0.160 |
Why?
| Gene-Environment Interaction | 2 | 2018 | 185 | 0.160 |
Why?
| Sleep, REM | 1 | 2018 | 32 | 0.150 |
Why?
| Visual Cortex | 1 | 2019 | 68 | 0.150 |
Why?
| Sex Factors | 3 | 2012 | 1949 | 0.150 |
Why?
| Mutagenesis, Site-Directed | 1 | 2018 | 358 | 0.140 |
Why?
| Autoradiography | 3 | 2009 | 74 | 0.140 |
Why?
| Myocarditis | 1 | 2018 | 97 | 0.140 |
Why?
| Cytochrome P-450 CYP2A6 | 1 | 2016 | 9 | 0.140 |
Why?
| Mutation | 4 | 2022 | 3692 | 0.140 |
Why?
| Acoustic Stimulation | 3 | 2015 | 325 | 0.140 |
Why?
| Pyramidal Cells | 1 | 2017 | 71 | 0.130 |
Why?
| Electroencephalography | 1 | 2018 | 393 | 0.130 |
Why?
| Proto-Oncogene Proteins | 1 | 2020 | 634 | 0.130 |
Why?
| Genetic Linkage | 1 | 1996 | 299 | 0.130 |
Why?
| Substance-Related Disorders | 1 | 2005 | 1011 | 0.130 |
Why?
| HEK293 Cells | 3 | 2015 | 681 | 0.130 |
Why?
| Alleles | 4 | 2013 | 845 | 0.130 |
Why?
| Time Factors | 6 | 2018 | 6503 | 0.130 |
Why?
| Down Syndrome | 1 | 2022 | 470 | 0.120 |
Why?
| Cerebral Cortex | 3 | 2009 | 420 | 0.120 |
Why?
| Cigarette Smoking | 1 | 2016 | 85 | 0.120 |
Why?
| Receptor, Melatonin, MT1 | 1 | 2015 | 6 | 0.120 |
Why?
| Mesencephalon | 1 | 2015 | 66 | 0.120 |
Why?
| Analysis of Variance | 2 | 2012 | 1271 | 0.120 |
Why?
| Isoxazoles | 1 | 2015 | 54 | 0.120 |
Why?
| Autoreceptors | 1 | 2014 | 4 | 0.120 |
Why?
| Pyrethrins | 1 | 2014 | 7 | 0.120 |
Why?
| Potassium Chloride | 1 | 2014 | 33 | 0.120 |
Why?
| Conotoxins | 2 | 2004 | 14 | 0.110 |
Why?
| Gene Expression Regulation, Developmental | 1 | 2019 | 815 | 0.110 |
Why?
| Phenylurea Compounds | 1 | 2015 | 89 | 0.110 |
Why?
| Neurogenesis | 1 | 2015 | 122 | 0.110 |
Why?
| Macrophages, Alveolar | 1 | 2017 | 379 | 0.110 |
Why?
| Social Behavior | 1 | 2017 | 287 | 0.110 |
Why?
| Calcineurin Inhibitors | 1 | 2014 | 59 | 0.110 |
Why?
| Heterozygote | 1 | 2015 | 266 | 0.110 |
Why?
| Mycobacterium tuberculosis | 1 | 2017 | 314 | 0.110 |
Why?
| Auditory Perception | 1 | 2015 | 111 | 0.110 |
Why?
| Prefrontal Cortex | 1 | 2017 | 297 | 0.110 |
Why?
| Presynaptic Terminals | 1 | 2014 | 68 | 0.110 |
Why?
| Crosses, Genetic | 2 | 2006 | 141 | 0.110 |
Why?
| Base Sequence | 4 | 2013 | 2134 | 0.110 |
Why?
| DNA, Intergenic | 1 | 2013 | 24 | 0.110 |
Why?
| Habituation, Psychophysiologic | 1 | 2014 | 53 | 0.110 |
Why?
| Haplotypes | 4 | 2018 | 471 | 0.110 |
Why?
| In Situ Hybridization | 3 | 2003 | 292 | 0.110 |
Why?
| Patch-Clamp Techniques | 2 | 2004 | 262 | 0.110 |
Why?
| Protein Kinase C | 1 | 2014 | 252 | 0.100 |
Why?
| Self Administration | 2 | 2019 | 122 | 0.100 |
Why?
| Sex Characteristics | 3 | 2012 | 727 | 0.100 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 937 | 0.100 |
Why?
| 3' Untranslated Regions | 1 | 2013 | 136 | 0.100 |
Why?
| Permeability | 1 | 2012 | 156 | 0.100 |
Why?
| In Vitro Techniques | 3 | 2003 | 1043 | 0.100 |
Why?
| Dihydro-beta-Erythroidine | 2 | 2010 | 5 | 0.100 |
Why?
| Rubidium Radioisotopes | 4 | 2004 | 8 | 0.090 |
Why?
| Statistics as Topic | 1 | 2012 | 304 | 0.090 |
Why?
| Alcoholism | 3 | 2008 | 766 | 0.090 |
Why?
| Transfection | 3 | 2013 | 895 | 0.090 |
Why?
| Food Preferences | 1 | 2012 | 112 | 0.090 |
Why?
| Myocardial Infarction | 1 | 2018 | 1014 | 0.090 |
Why?
| Gene Frequency | 2 | 2009 | 504 | 0.090 |
Why?
| Data Interpretation, Statistical | 1 | 2012 | 335 | 0.090 |
Why?
| Iodine Radioisotopes | 2 | 2009 | 142 | 0.090 |
Why?
| Amino Acid Sequence | 3 | 2004 | 2041 | 0.090 |
Why?
| Decamethonium Compounds | 1 | 2010 | 1 | 0.090 |
Why?
| Hexamethonium | 1 | 2010 | 4 | 0.090 |
Why?
| Mecamylamine | 1 | 2010 | 9 | 0.090 |
Why?
| Enzyme-Linked Immunosorbent Assay | 1 | 2012 | 814 | 0.080 |
Why?
| Xenopus laevis | 1 | 2010 | 97 | 0.080 |
Why?
| Animals, Newborn | 1 | 2012 | 805 | 0.080 |
Why?
| Electrophysiology | 1 | 2010 | 205 | 0.080 |
Why?
| Genetic Association Studies | 3 | 2018 | 359 | 0.080 |
Why?
| Organ Specificity | 1 | 2010 | 291 | 0.080 |
Why?
| Rats | 5 | 2013 | 5168 | 0.080 |
Why?
| Dithiothreitol | 2 | 1988 | 16 | 0.080 |
Why?
| Risk | 3 | 2019 | 852 | 0.080 |
Why?
| Receptor, Cannabinoid, CB1 | 1 | 2008 | 40 | 0.070 |
Why?
| Luciferases | 3 | 2013 | 147 | 0.070 |
Why?
| Columbidae | 1 | 2007 | 30 | 0.070 |
Why?
| Epilepsy | 2 | 2012 | 321 | 0.070 |
Why?
| Europe | 2 | 2022 | 362 | 0.070 |
Why?
| RNA, Messenger | 4 | 2015 | 2674 | 0.070 |
Why?
| Cocaine-Related Disorders | 1 | 2008 | 108 | 0.070 |
Why?
| Mice, Congenic | 1 | 2006 | 22 | 0.070 |
Why?
| Lod Score | 1 | 2006 | 66 | 0.070 |
Why?
| Drug Interactions | 2 | 2004 | 360 | 0.060 |
Why?
| RNA | 2 | 2010 | 881 | 0.060 |
Why?
| Thalamus | 2 | 2009 | 83 | 0.060 |
Why?
| Drinking Behavior | 1 | 2005 | 10 | 0.060 |
Why?
| Age of Onset | 2 | 2020 | 493 | 0.060 |
Why?
| Cadmium Chloride | 1 | 2004 | 4 | 0.060 |
Why?
| Reflex, Startle | 5 | 2017 | 67 | 0.060 |
Why?
| Macrocyclic Compounds | 1 | 2004 | 10 | 0.060 |
Why?
| Ryanodine | 1 | 2004 | 14 | 0.060 |
Why?
| Oxazoles | 1 | 2004 | 31 | 0.060 |
Why?
| Adult | 12 | 2016 | 35315 | 0.060 |
Why?
| Inhibitory Concentration 50 | 1 | 2004 | 81 | 0.060 |
Why?
| Age Factors | 1 | 2012 | 3117 | 0.060 |
Why?
| Algorithms | 1 | 2012 | 1616 | 0.060 |
Why?
| Snails | 1 | 2004 | 34 | 0.060 |
Why?
| Binding, Competitive | 3 | 2003 | 199 | 0.060 |
Why?
| Menthol | 1 | 2024 | 7 | 0.060 |
Why?
| Extracellular Space | 1 | 2004 | 120 | 0.060 |
Why?
| Membrane Potentials | 1 | 2004 | 260 | 0.060 |
Why?
| Tobacco Products | 2 | 2019 | 111 | 0.060 |
Why?
| Injections, Intraperitoneal | 2 | 2001 | 105 | 0.060 |
Why?
| Risk Factors | 5 | 2022 | 9727 | 0.050 |
Why?
| Mice, 129 Strain | 2 | 2015 | 80 | 0.050 |
Why?
| Sequence Analysis | 1 | 2003 | 38 | 0.050 |
Why?
| Middle Aged | 9 | 2019 | 30893 | 0.050 |
Why?
| Threonine | 1 | 2003 | 44 | 0.050 |
Why?
| Electroporation | 1 | 2003 | 37 | 0.050 |
Why?
| Tobacco Smoking | 1 | 2023 | 25 | 0.050 |
Why?
| Sequence Alignment | 1 | 2003 | 330 | 0.050 |
Why?
| Alanine | 1 | 2003 | 141 | 0.050 |
Why?
| Sample Size | 1 | 2022 | 115 | 0.050 |
Why?
| Suprachiasmatic Nucleus | 1 | 2022 | 15 | 0.050 |
Why?
| Luminescent Proteins | 1 | 2003 | 176 | 0.050 |
Why?
| Exons | 1 | 2003 | 337 | 0.050 |
Why?
| Reproducibility of Results | 1 | 2010 | 3023 | 0.050 |
Why?
| Green Fluorescent Proteins | 1 | 2003 | 382 | 0.050 |
Why?
| Synaptic Transmission | 1 | 2024 | 260 | 0.050 |
Why?
| DNA | 3 | 2010 | 1392 | 0.050 |
Why?
| Biological Transport, Active | 1 | 2001 | 72 | 0.050 |
Why?
| Genetic Loci | 1 | 2022 | 274 | 0.050 |
Why?
| Enzyme Inhibitors | 1 | 2004 | 811 | 0.050 |
Why?
| Adolescent | 7 | 2019 | 20213 | 0.050 |
Why?
| Serum Albumin, Bovine | 1 | 2001 | 61 | 0.050 |
Why?
| Gene Regulatory Networks | 1 | 2023 | 281 | 0.040 |
Why?
| DNA, Complementary | 1 | 2001 | 267 | 0.040 |
Why?
| Blotting, Western | 1 | 2003 | 1168 | 0.040 |
Why?
| Interneurons | 1 | 2001 | 118 | 0.040 |
Why?
| Injections, Intraventricular | 1 | 2000 | 53 | 0.040 |
Why?
| Molecular Sequence Data | 2 | 2004 | 2818 | 0.040 |
Why?
| Models, Biological | 1 | 2008 | 1693 | 0.040 |
Why?
| Blotting, Southern | 1 | 2000 | 68 | 0.040 |
Why?
| Odds Ratio | 2 | 2016 | 1022 | 0.040 |
Why?
| Hybridization, Genetic | 1 | 2000 | 79 | 0.040 |
Why?
| Feeding Behavior | 1 | 2005 | 617 | 0.040 |
Why?
| Hyperkinesis | 1 | 2019 | 17 | 0.040 |
Why?
| Gene Transfer Techniques | 1 | 2000 | 161 | 0.040 |
Why?
| Methylphenidate | 1 | 2019 | 37 | 0.040 |
Why?
| Dopamine Plasma Membrane Transport Proteins | 1 | 2019 | 47 | 0.040 |
Why?
| Cattle | 1 | 2001 | 962 | 0.040 |
Why?
| Protective Factors | 1 | 2018 | 91 | 0.040 |
Why?
| Linkage Disequilibrium | 2 | 2009 | 256 | 0.040 |
Why?
| Autophagosomes | 1 | 2017 | 19 | 0.040 |
Why?
| Mice, Inbred BALB C | 2 | 1999 | 1229 | 0.040 |
Why?
| Cells, Cultured | 2 | 2018 | 4008 | 0.030 |
Why?
| Protein Binding | 1 | 2003 | 2097 | 0.030 |
Why?
| Prepulse Inhibition | 1 | 2017 | 9 | 0.030 |
Why?
| Inflammasomes | 1 | 2018 | 128 | 0.030 |
Why?
| Receptors, Adrenergic, beta-2 | 1 | 2017 | 44 | 0.030 |
Why?
| Cell Line, Tumor | 2 | 2015 | 3160 | 0.030 |
Why?
| Young Adult | 4 | 2016 | 12320 | 0.030 |
Why?
| Kinetics | 4 | 2004 | 1616 | 0.030 |
Why?
| Radioimmunoassay | 1 | 1996 | 169 | 0.030 |
Why?
| Lung Neoplasms | 1 | 2009 | 2323 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2018 | 374 | 0.030 |
Why?
| Fluorescent Antibody Technique | 1 | 2017 | 374 | 0.030 |
Why?
| Binding Sites | 3 | 2007 | 1239 | 0.030 |
Why?
| CRISPR-Cas Systems | 1 | 2017 | 110 | 0.030 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2015 | 56 | 0.030 |
Why?
| Inflammation Mediators | 1 | 2018 | 500 | 0.030 |
Why?
| Autophagy | 1 | 2017 | 266 | 0.030 |
Why?
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 398 | 0.030 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2017 | 374 | 0.030 |
Why?
| DNA Primers | 2 | 2008 | 510 | 0.030 |
Why?
| Transcription Factors | 1 | 2022 | 1631 | 0.030 |
Why?
| Pulmonary Disease, Chronic Obstructive | 1 | 2021 | 950 | 0.030 |
Why?
| Mice, Inbred AKR | 2 | 2003 | 34 | 0.030 |
Why?
| Mice, Inbred A | 2 | 2003 | 47 | 0.030 |
Why?
| NF-kappa B | 1 | 2017 | 651 | 0.030 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2013 | 83 | 0.030 |
Why?
| Down-Regulation | 1 | 2015 | 629 | 0.030 |
Why?
| Cell Movement | 1 | 2017 | 937 | 0.030 |
Why?
| Lactation | 1 | 2014 | 170 | 0.030 |
Why?
| Polymerase Chain Reaction | 2 | 2008 | 1019 | 0.020 |
Why?
| Aged | 3 | 2018 | 21971 | 0.020 |
Why?
| Adolescent Development | 1 | 2012 | 82 | 0.020 |
Why?
| Case-Control Studies | 2 | 2010 | 3326 | 0.020 |
Why?
| Aged, 80 and over | 2 | 2015 | 7040 | 0.020 |
Why?
| Inflammation | 1 | 2021 | 2664 | 0.020 |
Why?
| Macrophages | 1 | 2018 | 1463 | 0.020 |
Why?
| Colorado | 1 | 2020 | 4392 | 0.020 |
Why?
| Prognosis | 1 | 2018 | 3780 | 0.020 |
Why?
| Dietary Supplements | 1 | 2014 | 529 | 0.020 |
Why?
| Plasmids | 1 | 2010 | 357 | 0.020 |
Why?
| Respiration | 3 | 2002 | 190 | 0.020 |
Why?
| Ligands | 2 | 2003 | 614 | 0.020 |
Why?
| Dizziness | 1 | 2010 | 80 | 0.020 |
Why?
| Autistic Disorder | 1 | 2012 | 186 | 0.020 |
Why?
| Receptors, Muscarinic | 1 | 1989 | 18 | 0.020 |
Why?
| Heart Rate | 4 | 2002 | 804 | 0.020 |
Why?
| Alkylation | 1 | 1988 | 24 | 0.020 |
Why?
| Pharmacogenetics | 1 | 1989 | 171 | 0.020 |
Why?
| Disulfides | 1 | 1988 | 96 | 0.020 |
Why?
| Receptors, Opioid | 1 | 1987 | 20 | 0.020 |
Why?
| Confidence Intervals | 1 | 2008 | 318 | 0.020 |
Why?
| Administration, Cutaneous | 1 | 2007 | 123 | 0.020 |
Why?
| Gene Deletion | 1 | 2009 | 372 | 0.020 |
Why?
| Family Health | 1 | 2008 | 194 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2008 | 512 | 0.020 |
Why?
| MicroRNAs | 1 | 2013 | 671 | 0.020 |
Why?
| Smoking Prevention | 1 | 2007 | 162 | 0.020 |
Why?
| Prospective Studies | 1 | 2018 | 7043 | 0.020 |
Why?
| Socioeconomic Factors | 1 | 2010 | 1197 | 0.020 |
Why?
| Nucleus Accumbens | 1 | 2007 | 128 | 0.020 |
Why?
| Cell Differentiation | 1 | 2013 | 1883 | 0.020 |
Why?
| Logistic Models | 1 | 2010 | 1975 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2008 | 1494 | 0.010 |
Why?
| Oxidation-Reduction | 1 | 1988 | 1001 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2012 | 2736 | 0.010 |
Why?
| Infant, Newborn | 1 | 2015 | 5687 | 0.010 |
Why?
| Receptors, Neurotransmitter | 1 | 2003 | 16 | 0.010 |
Why?
| Cloning, Molecular | 1 | 2004 | 522 | 0.010 |
Why?
| Substantia Nigra | 1 | 2003 | 56 | 0.010 |
Why?
| Smoking Cessation | 1 | 2007 | 408 | 0.010 |
Why?
| Mice, Mutant Strains | 1 | 2003 | 292 | 0.010 |
Why?
| Genomics | 1 | 2008 | 716 | 0.010 |
Why?
| Drug Tolerance | 3 | 1987 | 82 | 0.010 |
Why?
| Recombinant Fusion Proteins | 1 | 2004 | 632 | 0.010 |
Why?
| Infant | 1 | 2015 | 8913 | 0.010 |
Why?
| Recombinant Proteins | 1 | 2004 | 1284 | 0.010 |
Why?
| United States | 1 | 2018 | 13876 | 0.010 |
Why?
| Cell Count | 1 | 2001 | 314 | 0.010 |
Why?
| Hypothermia | 1 | 2001 | 35 | 0.010 |
Why?
| Veratridine | 1 | 2000 | 6 | 0.010 |
Why?
| Stimulation, Chemical | 1 | 2000 | 62 | 0.010 |
Why?
| Child, Preschool | 1 | 2015 | 10373 | 0.010 |
Why?
| Drug Resistance | 1 | 2001 | 163 | 0.010 |
Why?
| Recombination, Genetic | 1 | 2001 | 188 | 0.010 |
Why?
| Potassium | 1 | 2000 | 138 | 0.010 |
Why?
| Disease Susceptibility | 1 | 2001 | 334 | 0.010 |
Why?
| Cohort Studies | 1 | 2009 | 5369 | 0.010 |
Why?
| Genetic Testing | 1 | 2001 | 427 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2001 | 1669 | 0.010 |
Why?
| Child | 1 | 2015 | 20721 | 0.010 |
Why?
| Treatment Outcome | 1 | 2007 | 10163 | 0.010 |
Why?
| Quinuclidinyl Benzilate | 1 | 1989 | 2 | 0.010 |
Why?
| Dithionitrobenzoic Acid | 1 | 1986 | 1 | 0.000 |
Why?
| Rats, Inbred Strains | 1 | 1986 | 356 | 0.000 |
Why?
| Infusions, Intravenous | 1 | 1987 | 384 | 0.000 |
Why?
| Peptide Hydrolases | 1 | 1986 | 106 | 0.000 |
Why?
| Hot Temperature | 1 | 1986 | 362 | 0.000 |
Why?
| Oxygen Consumption | 1 | 1986 | 675 | 0.000 |
Why?
|
|
Stitzel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|